138 related articles for article (PubMed ID: 7522260)
1. Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan.
Hayashi J; Nakashima K; Yoshimura E; Kishihara Y; Ohmiya M; Hirata M; Kashiwagi S
J Infect; 1994 May; 28(3):271-7. PubMed ID: 7522260
[TBL] [Abstract][Full Text] [Related]
2. Inverse correlation between the titre of antibody to hepatitis C virus and the degree of hepatitis C viraemia.
Yoshimura E; Hayashi J; Tani Y; Ohmiya M; Nakashima K; Ikematsu H; Kinukawa N; Maeda Y; Kashiwagi S
J Infect; 1994 Sep; 29(2):147-55. PubMed ID: 7528759
[TBL] [Abstract][Full Text] [Related]
3. Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease.
Hayashi J; Nakashima K; Kishihara Y; Ohmiya M; Yoshimura E; Hirata M; Kashiwagi S
J Infect; 1993 May; 26(3):287-94. PubMed ID: 7685043
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan.
Hayashi J; Yoshimura E; Nabeshima A; Kishihara Y; Ikematsu H; Hirata M; Maeda Y; Kashiwagi S
J Gastroenterol; 1994 Jun; 29(3):276-81. PubMed ID: 7520320
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma.
Sakamoto N; Enomoto N; Marumo F; Sato C
J Med Virol; 1993 Jan; 39(1):11-5. PubMed ID: 7678636
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection in haemodialysis patients: a clinical and virological study.
Corcoran GD; Brink NS; Millar CG; Garson JA; Waite J; Deaville R; Thompson FD; Tedder RS
J Infect; 1994 May; 28(3):279-85. PubMed ID: 7522261
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.
Bukh J; Wantzin P; Krogsgaard K; Knudsen F; Purcell RH; Miller RH
J Infect Dis; 1993 Dec; 168(6):1343-8. PubMed ID: 7504031
[TBL] [Abstract][Full Text] [Related]
9. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?
Papadopoulos N; Griveas I; Sveroni E; Argiana V; Kalliaropoulos A; Martinez-Gonzalez B; Deutsch M
Int J Artif Organs; 2018 Mar; 41(3):168-170. PubMed ID: 29546809
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan.
Sheu JC; Lee SH; Wang JT; Shih LN; Wang TH; Chen DS
J Med Virol; 1992 Jun; 37(2):108-12. PubMed ID: 1378482
[TBL] [Abstract][Full Text] [Related]
13. Anti-C100-3 antibody status, viral genomic sequences, and clinical features in chronic hepatitic patients with hepatitis C virus RNA in sera.
Morii K; Shimomura H; Nakagawa H; Hasui T; Tsuji T
Acta Med Okayama; 1992 Aug; 46(4):285-93. PubMed ID: 1332424
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya.
Elzouki AN; Bushala M; Tobji RS; Khfaifi M
Nephrol Dial Transplant; 1995; 10(4):475-6. PubMed ID: 7542751
[No Abstract] [Full Text] [Related]
15. Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease.
al-Dhahry SH; Aghanashinikar PN; al-Hasani MK; Buhl MR; Daar AS
Infection; 1993; 21(3):164-7. PubMed ID: 7690010
[TBL] [Abstract][Full Text] [Related]
16. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL
Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction.
Inokuchi K; Nakata K; Hamasaki K; Daikoku M; Nakao K; Kato Y; Yatsuhashi H; Koga M; Yano M; Nagataki S
J Hepatol; 1996 Mar; 24(3):258-64. PubMed ID: 8778190
[TBL] [Abstract][Full Text] [Related]
18. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
19. Community prevalence of hepatitis C viraemia: a polymerase chain reaction study.
Sallie R; King R; Silva E; Tibbs C; Johnson P; Williams R
J Med Virol; 1994 Jun; 43(2):111-4. PubMed ID: 8083657
[TBL] [Abstract][Full Text] [Related]
20. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
